Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17499024rdf:typepubmed:Citationlld:pubmed
pubmed-article:17499024lifeskim:mentionsumls-concept:C0024530lld:lifeskim
pubmed-article:17499024lifeskim:mentionsumls-concept:C0030498lld:lifeskim
pubmed-article:17499024lifeskim:mentionsumls-concept:C0023676lld:lifeskim
pubmed-article:17499024lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:17499024lifeskim:mentionsumls-concept:C0014442lld:lifeskim
pubmed-article:17499024lifeskim:mentionsumls-concept:C0027280lld:lifeskim
pubmed-article:17499024lifeskim:mentionsumls-concept:C1136197lld:lifeskim
pubmed-article:17499024lifeskim:mentionsumls-concept:C1413742lld:lifeskim
pubmed-article:17499024lifeskim:mentionsumls-concept:C1523987lld:lifeskim
pubmed-article:17499024lifeskim:mentionsumls-concept:C0027289lld:lifeskim
pubmed-article:17499024pubmed:issue7lld:pubmed
pubmed-article:17499024pubmed:dateCreated2007-6-25lld:pubmed
pubmed-article:17499024pubmed:abstractTextThe operation of a type II NADH:quinone oxidoreductase (PfNDH2), also known as alternative Complex I, in the mitochondrion of the human malaria parasite, Plasmodium falciparum, has recently been described. Unlike the Complex I of typical mitochondria, type II NADH:quinone oxidoreductases do not have transmembrane domains and are not involved directly in proton (H(+)) pumping. Here, we present a predictive model of PfNDH2, describing putative NADH-, flavin- and quinone-binding sites, as well as a possible membrane 'anchoring' region. In addition, we hypothesize that the alternative Complex I is an evolutionary adaptation to a microaerophilic lifestyle enabling (proton) uncoupled oxidation of NADH. This adaptive feature has several advantages, including: (i) a reduction of proton 'back-pressure' in the absence of extensive ATP synthesis; (ii) a reduction of mitochondrial superoxide generation; and (iii) a mechanism for the deregulated oxidation of cytosolic NADH.lld:pubmed
pubmed-article:17499024pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17499024pubmed:languageenglld:pubmed
pubmed-article:17499024pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17499024pubmed:citationSubsetIMlld:pubmed
pubmed-article:17499024pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17499024pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17499024pubmed:statusMEDLINElld:pubmed
pubmed-article:17499024pubmed:monthJullld:pubmed
pubmed-article:17499024pubmed:issn1471-4922lld:pubmed
pubmed-article:17499024pubmed:authorpubmed-author:BrayPatrick...lld:pubmed
pubmed-article:17499024pubmed:authorpubmed-author:WardStephen...lld:pubmed
pubmed-article:17499024pubmed:authorpubmed-author:BiaginiGianca...lld:pubmed
pubmed-article:17499024pubmed:authorpubmed-author:FisherNichola...lld:pubmed
pubmed-article:17499024pubmed:issnTypePrintlld:pubmed
pubmed-article:17499024pubmed:volume23lld:pubmed
pubmed-article:17499024pubmed:ownerNLMlld:pubmed
pubmed-article:17499024pubmed:authorsCompleteYlld:pubmed
pubmed-article:17499024pubmed:pagination305-10lld:pubmed
pubmed-article:17499024pubmed:dateRevised2008-3-27lld:pubmed
pubmed-article:17499024pubmed:meshHeadingpubmed-meshheading:17499024...lld:pubmed
pubmed-article:17499024pubmed:meshHeadingpubmed-meshheading:17499024...lld:pubmed
pubmed-article:17499024pubmed:meshHeadingpubmed-meshheading:17499024...lld:pubmed
pubmed-article:17499024pubmed:meshHeadingpubmed-meshheading:17499024...lld:pubmed
pubmed-article:17499024pubmed:meshHeadingpubmed-meshheading:17499024...lld:pubmed
pubmed-article:17499024pubmed:meshHeadingpubmed-meshheading:17499024...lld:pubmed
pubmed-article:17499024pubmed:meshHeadingpubmed-meshheading:17499024...lld:pubmed
pubmed-article:17499024pubmed:meshHeadingpubmed-meshheading:17499024...lld:pubmed
pubmed-article:17499024pubmed:meshHeadingpubmed-meshheading:17499024...lld:pubmed
pubmed-article:17499024pubmed:meshHeadingpubmed-meshheading:17499024...lld:pubmed
pubmed-article:17499024pubmed:meshHeadingpubmed-meshheading:17499024...lld:pubmed
pubmed-article:17499024pubmed:year2007lld:pubmed
pubmed-article:17499024pubmed:articleTitleThe malaria parasite type II NADH:quinone oxidoreductase: an alternative enzyme for an alternative lifestyle.lld:pubmed
pubmed-article:17499024pubmed:affiliationLiverpool School of Tropical Medicine, Pembroke Place, Liverpool, L3 5QA, UK.lld:pubmed
pubmed-article:17499024pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17499024pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17499024lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17499024lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17499024lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17499024lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17499024lld:pubmed